Carelane
United States
- Boston, Massachusetts
- 27/06/2024
- Pre-Seed
- $855,032
Enabling Real World Evidence trials.
- Industry Software Development
- Website https://www.carelane.io/
- LinkedIn https://www.linkedin.com/company/carelane/
Related People
Gustav V.Co Founder
United States -
Boston, Massachusetts
I have been working in the domain of healthcare, clinical research and qualified software development for more than 20 years. My focus has been on clinical trials of all types and phases, supporting sponsors, study sites, collaborative groups, and pharma with clinical data management and source data integration.
Be it as team lead of the clinical informatics unit at the largest comprehensive cancer center in Germany, as co-founder of a medical software startup, or as active member of HL7 Biomedical Research and Regulation Work Group and HL7 Vulcan, I have been passionate about bringing clinical research and clinical care closer together. Now I am on a new mission to simplify and improve the way clinical research is conducted. Stay tuned.
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)